Verapamil Hydrochloride Injection, Solution
Product Images NDC 51662-1398

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 51662-1398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00351662139820 Verapamil Pouch Label

Label of VERAPAMIL HYDROCHLORIDE injection solution, USP 10 mg/4 mL (2.5 mg/mL) 4 mL vial. The label includes the NDC code 51662-1398-2, lot number 12345, expiration date 2025-01-01, storage instructions, and manufacturer information for HF Acquisition Co LLC, DBA HealthFirst. It is marked for intravenous use only and states Rx only.*

FDA Label Image

00351662139837 Verapamil Rfid Label

A small white rectangular medication label featuring a 2D barcode and several lines of black printed text, including numeric codes in parentheses (01), (17), (21), and (10). The label states distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275. The product is associated with Verapamil Hydrochloride injection, solution, 2.5 mg/mL, for intravenous use.*

FDA Label Image

00351662139837 Verapamil Case Label

Label for Verapamil Hydrochloride Injection USP, 10 mg/4 mL (2.5 mg/mL) in a 4 mL vial, box of 25, manufactured by HF Acquisition Co LLC, DBA HealthFirst. The label includes NDC 51662-1398-3, lot number 12345, and expiration date 2025-01-01, along with storage instructions and prescription-only status.*

FDA Label Image

Adverse Reactions (Adverse Reaction)

A data table titled "Suggested Treatment of Acute Cardiovascular Adverse Reactions" listing adverse reactions, proven effective treatments, and supportive treatments. It covers treatments for symptomatic hypotension, bradycardia, AV block, asystole, and rapid ventricular rate related to atrial fibrillation/flutter, including intravenous medications and supportive care measures like intravenous fluids and cardiac pacing.*

FDA Label Image

How Supplied (How Supplied)

A data table listing NDC product configurations for Verapamil Hydrochloride injection solution, showing unit of sale, concentration, and package types including ampuls, plastic syringes, and flitop vials with concentrations ranging from 2.5 mg/mL to 5 mg/2 mL and package sizes from 2 mL ampuls to trays containing 25 vials.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of verapamil hydrochloride illustrating the molecular arrangement of atoms including methoxy groups, nitrile, and hydrochloride components.*

FDA Label Image

Serialized Vial Labeling (Serialized Vial)

VERAPAMIL HYDROCHLORIDE injection, USP 2.5 mg/mL in a 4 mL single-dose glass vial with a gray cap. The label includes a barcode and product identifiers, distributed by HF Acquisition Co LLC, DBA HealthFirst. The vial contains a clear solution intended for intravenous use.*

FDA Label Image

Vial Part 1 (Vial Part 1)

Verapamil Hydrochloride Injection, USP 10 mg (2.5 mg/mL) in a 4 mL single-dose clear glass vial with a grey flip-off top. The label shows the product name, strength, dosage form, and the manufacturer Hospira, Inc., Lake Forest, IL, USA.*

FDA Label Image

Vial Laeling Part 2 (Vial Part 2)

Clear glass vial of VERAPAMIL HYDROCHLORIDE 2.5 mg/mL injection solution for intravenous use. The label includes dosage strength, a note to protect from light, and the NDC 0409-1144-02. The vial has a metal cap with a white rubber stopper. Manufacturer details note a location in Illinois, USA.*

FDA Label Image

Vial Labeling Part 3 (Vial Part 3)

Verapamil Hydrochloride injection vial label showing a solution for intravenous use. The label includes an NDC number 0409-1144-02, a note that it is for prescription use only, and storage instructions to protect from light. The lot or expiration date shown is 1 JUL 2020. The source labeler information is not fully visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.